Results 141 to 150 of about 12,109,428 (256)

TPI1 Loss Triggers a Metabolite‐Driven Mitochondrial Redox Vulnerability via the SARM1–cADPR–Ca2+ Axis

open access: yesAdvanced Science, EarlyView.
Metabolite‐driven redox stress governs cancer cell senescence. TPI1 deficiency elevates DHAP, initiating SARM1‐dependent cADPR‐Ca2+ release. Mitochondrial ROS surge subsequently induces DNA damage and senescence, offering a conserved therapeutic target in multiple cancers.
Chunyu Liu   +15 more
wiley   +1 more source

Hypoxia-specific MRI contrast agents

open access: yes, 2018
Introduction: Hypoxia or decreased availability of oxygen in tumours is of significant interest in oncology as it is known to increase radiotherapy and chemotherapy resistance, and promote tumour progression [1, 2]. For better prognosis of solid tumours,
Wijesekera, Nadeeja (S32280)   +3 more
core  

A Programmable Calcification Nanoplatform for Loco‐Regional Calcification‐Immune Hepatocellular Carcinoma Therapy

open access: yesAdvanced Science, EarlyView.
An in situ‐grown BP‐CaO2 nanoplatform supplies coordinated Ca2+, endogenous phosphate, and oxidative stress to convert tumor calcification from a passive endpoint into an active immune‐remodeling process. Widespread hydroxyapatite deposition is visualized by CT, while multi‐omics reveals MCOLN2 as a calcium‐responsive mediator linking biomineralization
Long Liu   +11 more
wiley   +1 more source

Identifying a Csmd3+ Microglial Subpopulation that Drives Cold‐to‐Hot Transition and Immune‐Cure in Glioblastoma

open access: yesAdvanced Science, EarlyView.
The study establishes an immune‐cure (ICu) mouse model based on a TMEMed G422TN‐GBM system that faithfully recapitulates human TMEMed GBM. scRNA‐seq analysis reveals a Csmd3+ microglial subset with innate immune memory (IIM) potential that potently suppresses GBM growth, drives a TME cold‐to‐hot transition, and induces 100% ICu in long‐term survival ...
Hai‐Feng Jiang   +12 more
wiley   +1 more source

Recurrent diffuse tenosynovial giant cell tumour of knee joint with emphasis on treatment trends: a case report

open access: yesJournal of Current Oncology and Medical Sciences
Introduction: Tenosynovial giant cell tumor is a benign lesion that frequently recurs locally. The recurrence rate is quite high for diffuse tenosynovial giant cells.
Siddharth Arora   +3 more
doaj  

Establishment of image-guided radiotherapy of orthotopic hepatocellular carcinoma mouse model. [PDF]

open access: yesAnimal Model Exp Med, 2023
Zhou K   +6 more
europepmc   +1 more source

Targeting Tex10 Overcomes Oxaliplatin Resistance by Competitively Disrupting the Non‐Canonical BAF Complex in Colorectal Cancer

open access: yesAdvanced Science, EarlyView.
This study reveals that Tex10 drives oxaliplatin resistance in colorectal cancer by competitively binding BRD9 to disrupt the ncBAF complex, thereby suppressing AMBRA1 transcription and ULK1‐mediated autophagy. Gemcitabine is identified as a direct Tex10 inhibitor that restores autophagy and overcomes resistance.
Ping Xu   +9 more
wiley   +1 more source

Augmented reality image overlay projection for image guided open liver ablation of metastatic liver cander

open access: yes, 2011
ARTORG Center - Chair for Image Guided ...
Anderegg, S   +4 more
core  

Image guided radiotherapy and the role radiology assistant in it

open access: yes, 2014
Bakalářská práce se zabývá obrazem naváděnou radioterapií a úlohou radiologického asistenta při ní. Práce je rozdělena na dvě části, na teoretickou a praktickou.
Štrof, Vojtěch
core   +1 more source

GM‐CSF Promotes Neutrophil PD‐L1 Expression Through the VEGFR‐2/STAT6/CSF2 Signaling Axis in Oral Squamous Cell Carcinoma

open access: yesAdvanced Science, EarlyView.
VEGFR‐2 signaling in OSCC activates Src–STAT6‐dependent CSF2 transcription, driving tumor‐derived GM‐CSF secretion. GM‐CSF programs neutrophils to express PD‐L1 through STAT5–mTOR/S6K signaling, suppressing cytotoxic CD8+ T cells. This pathway reveals a tumor–neutrophil immune checkpoint circuit that limits anti‐PD‐1 responsiveness in OSCC.
Fangxing Zhu   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy